Compounded Medication – Prescription Only

This product is a compounded injectable formulation containing a standardized blend of amino acids and lidocaine, supplied in a sterile injectable vial and dispensed only pursuant to a valid prescription issued by a licensed healthcare provider.

In compounding practice, combination amino acid formulations may be prescribed when a provider determines that individualized formulation or concentration considerations are clinically appropriate for a specific patient. This product is not available for self-selection and may only be dispensed following provider authorization.

Compounded medications are not approved by the U.S. Food and Drug Administration (FDA). The FDA does not evaluate compounded formulations for safety, effectiveness, or quality. Compounding is performed by a state-licensed pharmacy pursuant to a patient-specific prescription.

This page provides general, non-therapeutic information for educational and compliance purposes only. It does not describe intended use, therapeutic benefit, physiologic effect, or expected clinical outcomes.

General Scientific Information (Non-Therapeutic)

Amino Max contains a combination of essential and conditionally essential amino acids, along with lidocaine. Amino acids are organic compounds referenced in scientific literature for their molecular structures and participation in protein synthesis and biochemical pathways.

Lidocaine is a pharmaceutical compound classified as a local anesthetic and has been studied for its effects on nerve signal transmission at the cellular level.

Descriptions of molecular characteristics or biochemical properties are provided solely for general scientific context. No claims are made regarding safety, effectiveness, performance enhancement, clinical effects, or suitability for any particular condition.

Contraindications

Amino Max injection should not be used in individuals who:

• Have a known hypersensitivity or allergy to lidocaine, amino acids, or any component of the compounded formulation
• Have experienced prior adverse reactions to lidocaine-containing injectable products
• Have a known hypersensitivity to local anesthetics of the amide type
• Are unable to tolerate injectable therapies as determined by the prescribing healthcare provider
• Use in pregnant or breastfeeding individuals should occur only if a licensed healthcare provider determines that potential risks and benefits have been carefully evaluated.

Warnings and Precautions

Lidocaine may affect cardiac conduction and central nervous system activity. Caution is advised in individuals with underlying cardiovascular conditions, conduction abnormalities, or seizure disorders.

Systemic absorption of lidocaine may occur, particularly with higher cumulative exposure. Patients should be monitored for signs of lidocaine toxicity, including dizziness, confusion, numbness, or abnormal heart rhythm.

Injectable administration should be performed only as prescribed and supervised by a licensed medical provider.

Patients should inform their healthcare provider of all medical conditions, allergies, and medications prior to receiving this compounded formulation.

Potential Side Effects

Reported side effects associated with amino acid and lidocaine-containing injectable formulations may include:

• Injection site reactions such as pain, redness, swelling, or irritation
• Numbness or tingling at or near the injection site
• Dizziness or lightheadedness
• Headache
• Nausea
• Transient changes in heart rate or blood pressure

Serious adverse reactions are uncommon but may occur. Patients should seek immediate medical attention if they experience symptoms of a severe allergic reaction, cardiac irregularities, difficulty breathing, or neurologic symptoms.